Abstract

In previous studies, we demonstrated that T cell receptor (TCR) Vβ8.2 and Vβ10, both of which are frequently used by encephalitogenic T cells, spectratypes expand oligoclonally in spinal cord lesions of Lewis rats with experimental autoimmune encephalomyelitis (EAE) and that the DSSYEQYF and WDGSGNVLYF sequences are predominantly found in the complementarity-determining region 3 (CDR3) of spectratype-derived TCR clones. However, it is unknown whether these CDR3 sequences are used only by Vβ8.2- and Vβ10-positive T cells or by encephalitogenic T cells bearing Vβs other than these Vβs. The present study was undertaken to address this issue using a new approach, i.e. CDR3 spectratyping and subsequent DNA hybridization with several probes corresponding to various parts of the CDR3 region. Consequently, we found that probes specific for the Vβ8.2 spectratype-derived Dβ and Jβ2.7 hybridized only with the Vβ8.2 spectratype in acute EAE and with the Vβ8.2 and Vβ12 spectratypes in chronic relapsing EAE. Similarly, a probe specific for the Vβ10 spectratype-derived Dβ hybridized only with the Vβ10 spectratype in both acute and chronic relapsing EAE. In contrast, a probe specific for Jβ1.3 hybridized with several Vβ spectratypes including Vβ8.2 and Vβ10 only during the early stage of the disease. These findings suggest that T cells bearing a few Vβs with a limited number of the CDR3 sequences are activated in acute and chronic relapsing EAE induced in Lewis rats. Characterization of the CDR3 region of pathogenic TCR by this approach may be of value for the screening of autoimmune disease-associated TCR and for the development of TCR-based specific immunotherapy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call